EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)Vergleichsstudie

Comparison of the Efficacy and Safety of Biosimilar Adalimumab Injection with Innovator Adalimumab in Subjects with Active Ankylosing Spondylitis

S Chandrashekara, Jyoti Ranjan Parida, Archana Sonawale, Vishnu Sharma, Kaushik Basu, John Mathew, Chethana Dharmapalaiah, Gaurav Seth, Girish Kakade, Neeraj Jain, Reena Sharma, Firdaus Fatima und 13 weitere

Journal of The Association of Physicians of India · 2025

DOI: 10.59556/japi.73.1117 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of The Association of Physicians of India, 2025. Verfasst von S Chandrashekara und 24 weiteren Autor:innen. Beteiligte Einrichtung: Managing Director, Department of Rheumatology, ChanRe Rheumatology and Immunology Center and Research, Bengaluru, Karnataka, India, Orcid: https://or…. Hauptthemen laut MEDLINE: Adalimumab, Biosimilar Pharmaceuticals, Spondylitis, Ankylosing, Antirheumatic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdalimumabBiosimilar PharmaceuticalsSpondylitis, AnkylosingAntirheumatic AgentsHumansAdultMaleFemaleDouble-Blind MethodProspective StudiesInjections, SubcutaneousIndiaTreatment OutcomeMiddle Aged

Substanzen

AdalimumabBiosimilar PharmaceuticalsAntirheumatic Agents

Autor:innen und Institutionen

  • Managing Director, Department of Rheumatology, ChanRe Rheumatology and Immunology Center and Research, Bengaluru, Karnataka, India, Orcid: https://orcid.org/0000-0003-2661-9840, Corresponding Author.
  • Odisha Arthritis and Rheumatology Center, Bhubaneswar, Odisha, India.
  • Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India, Orcid: https://orcid.org/0000-0002-5717-0559.
  • Avron Hospitals Pvt. Ltd., Ahmedabad, Gujarat, India, Orcid: https://orcid.org/0009-0005-2741-2472.
  • Medical College and Hospital, Kolkata, West Bengal, India, Orcid: https://orcid.org/0009-0006-7007-5536.
  • Christian Medical College, Vellore, Tamil Nadu, India, Orcid: https://orcid.org/0000-0002-9857-2271.

Zitieren

APA

Chandrashekara, S., Parida, J. R., Sonawale, A., Sharma, V., Basu, K., Mathew, J., Dharmapalaiah, C., Seth, G., Kakade, G., Jain, N., Sharma, R., Fatima, F., Srivastava, R. N., Shah, R., Desai, B., Nalawade, A., Haridas, V., Kumar, U., Naidu, A. R., …, & Pawar, D. (2025). Comparison of the Efficacy and Safety of Biosimilar Adalimumab Injection with Innovator Adalimumab in Subjects with Active Ankylosing Spondylitis. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.73.1117

Vancouver

Chandrashekara S, Parida JR, Sonawale A, Sharma V, Basu K, Mathew J, et al. Comparison of the Efficacy and Safety of Biosimilar Adalimumab Injection with Innovator Adalimumab in Subjects with Active Ankylosing Spondylitis. Journal of The Association of Physicians of India. 2025. doi:10.59556/japi.73.1117

BibTeX
@article{Chandrashekara2025,
  author = {Chandrashekara, S and Parida, Jyoti Ranjan and Sonawale, Archana and Sharma, Vishnu and Basu, Kaushik and Mathew, John and Dharmapalaiah, Chethana and Seth, Gaurav and Kakade, Girish and Jain, Neeraj and Sharma, Reena and Fatima, Firdaus and Srivastava, Rajeshwar Nath and Shah, Romi and Desai, Bankim and Nalawade, Ajit and Haridas, Vikram and Kumar, Uma and Naidu, A Ramakrishnam and Pawar, Roshan and Aiwale, Amol and Rane, Yogesh and Shahavi, Vinayaka and Sharma, Akhilesh and Pawar, Dattatreya},
  title = {Comparison of the Efficacy and Safety of Biosimilar Adalimumab Injection with Innovator Adalimumab in Subjects with Active Ankylosing Spondylitis},
  journal = {Journal of The Association of Physicians of India},
  year = {2025},
  doi = {10.59556/japi.73.1117}
}
Kostenlos starten →